Product Name:4-hydroxy-6-oxo-1H-pyridazine-3-carboxylic acid

IUPAC Name:4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylic acid

CAS:1442437-21-9
Molecular Formula:C5H4N2O4
Purity:95%+
Catalog Number:CM325395
Molecular Weight:156.1

Packing Unit Available Stock Price($) Quantity
CM325395-5g in stock NJƀŴ
CM325395-10g in stock țɅȁ
CM325395-25g in stock ŴǧŴ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1442437-21-9
Molecular Formula:C5H4N2O4
Melting Point:-
Smiles Code:O=C(C(C(O)=C1)=NNC1=O)O
Density:
Catalog Number:CM325395
Molecular Weight:156.1
Boiling Point:
MDL No:MFCD30489098
Storage:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

Column Infos

Deucravacitinib
BMY announced new four-year Sotyktu (deucravacitinib) data demonstrating durable response rates and consistent safety in moderate-to-severe plaque psoriasis. Deucravacitinib is a specific, oral, intracellular TYK2 inhibitor that targets immune responses driven by type 1 IFN and IL-23 that contribute to psoriasis pathogenesis, including IL-17 production and Th1/Th17 polarization.